Vagner Oliveira-Duarte

Suggest Changes
Learn More
OBJECTIVE To evaluate hematological, cytogenetic and molecular responses as well as the overall, progression-free and event-free survivals of chronic myeloid leukemia patients treated with a third(More)
  • 1